ArticleBiology direct2026
AdipokineDis: multi-angle dissection of adipokine atlas highlights pivotal roles in pathophysiological processes with therapeutic potential.
Article in Biology direct, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Adipokines, a class of adipocyte-derived biologically active substances, have a critical role in regulating diverse physiological and pathophysiological processes, spanning metabolism, immunity and tumorigenesis. Despite the recognized involvement of adipocyte-secreted adipokines in multiple complex human diseases, the absence of a systematic dissection of adipokine repertoires severely hinders efforts to elucidate their molecular mechanisms and therapeutic potential in pathological contexts. To address this challenge and exhaustively reveal adipokine atlas and associations with complex diseases, we found that many adipokines showed functional heterogeneity via multiomics analysis based on reported adipokine datasets, and specific molecular alterations were associated with oncogenic pathways during tumorigenesis, demonstrating roles of adipokines in cancer subtyping and prognostic stratification. Adipokine-related networks may contextualize the disease-specific signature and delineate actionable insights for clinical potential, particularly ncRNA-mediated regulatory network and genetic interactions as actionable therapeutic vulnerabilities based on the concept of synthetic lethality. Further, a user-friendly and integrative AdipokineDis database ( https://www.tmliang.cn/adiDB/#/home ) was developed, focusing on adipokines and diseases. AdipokineDis contained multilayered annotations of adipokines, molecular landscapes and clinical estimation, adipokine-related genetic networks and evolutionary patterns, aiming to provide a comprehensive survey for adipokines and a novel perspective to address adipokine profiles in physiological and pathophysiological processes via bridging basic adipokine research with clinical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.